- Trials with a EudraCT protocol (28,977)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
28,977 result(s) found for: Informed Consent.
Displaying page 229 of 1,449.
| EudraCT Number: 2016-004957-33 | Sponsor Protocol Number: E2090-S082-405 | Start Date*: 2017-02-13 |
| Sponsor Name:Eisai Korea Inc. | ||
| Full Title: Comparative Study of Zonisamide and Carbamazepine as an Initial Monotherapy: Efficacy and Safety Evaluation | ||
| Medical condition: Epilepsy | ||
| Disease: | ||
| Population Age: Adolescents, Under 18, Adults | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2017-001284-20 | Sponsor Protocol Number: BIOGIO | Start Date*: 2017-07-05 |
| Sponsor Name:Erasmus MC Cancer Institute | ||
| Full Title: The effects of the proton pump inhibitor esomeprazole on the bioavailability of afatinib (Giotrif®) in patients with non-small cell lung cancer (NSCLC) 'the BIO-GIO study' | ||
| Medical condition: Non small cell lung cancer | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2014-001707-53 | Sponsor Protocol Number: CYD13 | Start Date*: 2014-05-26 |
| Sponsor Name:Sanofi Pasteur SA | ||
| Full Title: Immunogenicity and Safety of Sanofi Pasteur's CYD Dengue Vaccine in Healthy Children and Adolescents in Latin America | ||
| Medical condition: Prevention of symptomatic dengue disease | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2014-001737-88 | Sponsor Protocol Number: CYD57 | Start Date*: 2014-05-26 |
| Sponsor Name:Sanofi Pasteur SA | ||
| Full Title: Long-Term Safety Follow-Up of Thai Children Who Were Included in an Efficacy Study of a Tetravalent Dengue Vaccine | ||
| Medical condition: Prevention of symptomatic dengue disease | ||
| Disease: | ||
| Population Age: Children, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2015-003621-33 | Sponsor Protocol Number: ESR-15-10793 | Start Date*: 2016-02-25 | |||||||||||
| Sponsor Name:Fundación Interhospitalaria de Investigación Cardiovascular | |||||||||||||
| Full Title: PRotective Effect on the coronary microcirculation of patients with DIabetes by Clopidogrel or Ticagrelor:A randomized multicenter clinical trial using intracoronary multimodal physiology | |||||||||||||
| Medical condition: Ischemic Heart Disease in Diabetic patients | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: ES (Prematurely Ended) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2015-002588-40 | Sponsor Protocol Number: CAIN457ADE02T | Start Date*: 2016-05-31 | |||||||||||
| Sponsor Name:University Hospital Schleswig-Holstein | |||||||||||||
| Full Title: Exploratory Evaluation of Biomarkers associated with Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients | |||||||||||||
| Medical condition: moderate-to-severe psoriasis | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
| EudraCT Number: 2014-001816-20 | Sponsor Protocol Number: 1.1000 | Start Date*: 2014-08-28 |
| Sponsor Name:Academic Medical Center, Amsterdam | ||
| Full Title: Fractional CO2 laser assisted delivery of topical anesthetics: a randomized controlled pilot study | ||
| Medical condition: local anesthesia of the skin prior to minor cutaneous surgical procedures | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: NL (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2016-003444-37 | Sponsor Protocol Number: ENTERR06929 | Start Date*: 2016-08-26 | |||||||||||
| Sponsor Name:Sanofi | |||||||||||||
| Full Title: Bacillus clausii in the treatment of acute community–acquired diarrhea among Latin American children (cadiLAc) | |||||||||||||
| Medical condition: Diarrhea | |||||||||||||
|
|||||||||||||
| Population Age: Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: Outside EU/EEA | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2016-004755-75 | Sponsor Protocol Number: MICROPREP | Start Date*: 2017-09-28 |
| Sponsor Name:Clinique Juge | ||
| Full Title: Intra articular injection of microfat and platelet-rich plasma in the treatment of knee osteoarthritis : a pilot study | ||
| Medical condition: knee osteoarthritis | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: FR (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2017-001708-31 | Sponsor Protocol Number: Protokol_PPB_ACL_21042017 | Start Date*: 2017-06-20 | |||||||||||
| Sponsor Name:Aarhus University Hospital | |||||||||||||
| Full Title: The effect of the popliteal plexus block on postoperative pain after reconstruction of the anterior cruciate ligament | |||||||||||||
| Medical condition: Postoperative pain after reconstruction of the anterior cruciate ligament | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male, Female | ||||||||||||
| Trial protocol: DK (Completed) | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2017-005065-47 | Sponsor Protocol Number: TM-105 | Start Date*: 2018-05-15 |
| Sponsor Name:TikoMed AB | ||
| Full Title: A single-centre, open single-arm study where the safety, tolerability and efficacy of subcutaneously administered ILB will be evaluated in patients with Amyotrophic Lateral Sclerosis | ||
| Medical condition: Amyotrophic Lateral Sclerosis (ALS) | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male, Female | |
| Trial protocol: SE (Prematurely Ended) | ||
| Trial results: View results | ||
| EudraCT Number: 2014-005032-34 | Sponsor Protocol Number: MK-0991-058 | Start Date*: 2015-02-27 |
| Sponsor Name:Merck & Co., Inc. | ||
| Full Title: A Multicenter, Sequential-Panel, Open-Label, Noncomparative Study to Investigate the Safety, Tolerability, and Pharmacokinetics of Caspofungin Acetate in Neonates and Infants Less Than 3 Months of ... | ||
| Medical condition: Empirical therapy for fungal infections | ||
| Disease: | ||
| Population Age: Infants and toddlers, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2017-000772-28 | Sponsor Protocol Number: DUroNorr2 | Start Date*: 2017-05-16 |
| Sponsor Name:Johan Styrke | ||
| Full Title: Fosfomycin vs Ciprofloxacin for transrectal biopsy - a randomized controlled phaze II multicentre clinical trial | ||
| Medical condition: Prophylaxis of bacterial infections following prostate biopsies | ||
| Disease: | ||
| Population Age: Adults, Elderly | Gender: Male | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-004820-69 | Sponsor Protocol Number: CSLCT-FLU-04-05 | Start Date*: 2016-08-05 |
| Sponsor Name:CSL Limited | ||
| Full Title: An Open-Label, Multi-Centre Study to Evaluate the Safety, Tolerability and Immunogenicity of CSL's Influenza Vaccine in a Paediatric Population (= or >6 Months to < 9 Years of Age). | ||
| Medical condition: Influenza, human | ||
| Disease: | ||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2016-003704-31 | Sponsor Protocol Number: ARG-16 | Start Date*: 2019-05-17 |
| Sponsor Name:Uppsala University | ||
| Full Title: Impact on the intestinal microbiota during antibiotic treatment | ||
| Medical condition: Impact on the intestinal microbiota during antibiotic treatment | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: SE (Completed) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2020-001960-28 | Sponsor Protocol Number: RCTVITD/SARS-CoV-19 | Start Date*: 2020-05-25 |
| Sponsor Name:Investigation Institute Bioaraba | ||
| Full Title: Efficacy of vitamin D treatment in patients diagnosed with pneumonia who require hospital admission and have vitamin D deficiency and a positive diagnosis for SARS-Cov-2 (COVID-19) | ||
| Medical condition: COVID-19 infection | ||
| Disease: | ||
| Population Age: Adults | Gender: Male, Female | |
| Trial protocol: ES (Ongoing) | ||
| Trial results: (No results available) | ||
| EudraCT Number: 2015-004874-13 | Sponsor Protocol Number: AUG102821 | Start Date*: 2016-08-03 |
| Sponsor Name:GlaxoSmithKline | ||
| Full Title: An open label study to determine the pharmacokinetic profiles of amoxicillin and clavulanate in adolescent patients weighing at least 40kg and no more than 16 years of age receiving AUGMENTIN™XR ... | ||
| Medical condition: acute bacterial sinusitis | ||
| Disease: | ||
| Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |
| Trial protocol: Outside EU/EEA | ||
| Trial results: View results | ||
| EudraCT Number: 2015-001245-89 | Sponsor Protocol Number: BDR4580 | Start Date*: 2015-04-13 | |||||||||||
| Sponsor Name:Sanofi-aventis | |||||||||||||
| Full Title: Relative bioavailability study between 75 mg tablet and 75 mg solution of Clopidogrel (SR25990C) after single oral administration to young healthy men. Open, crossover, randomized and monocenter study | |||||||||||||
| Medical condition: Young healthy men (intended indication cardiovascular disease) | |||||||||||||
|
|||||||||||||
| Population Age: Adults | Gender: Male | ||||||||||||
| Trial protocol: Outside EU/EEA | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2014-004636-19 | Sponsor Protocol Number: ENTER_L_01486 | Start Date*: 2015-04-10 | |||||||||||
| Sponsor Name:Sanofi Aventis | |||||||||||||
| Full Title: Phase III Comparative Study to Assess the Efficacy and Safety of Oral Rehydration Therapy (ORT) in Combination With Spores of Bacillus Clausii (Enterogermina)Versus ORT Alone, Administered for 5 Da... | |||||||||||||
| Medical condition: Acute diarrhea | |||||||||||||
|
|||||||||||||
| Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
| Trial protocol: Outside EU/EEA | |||||||||||||
| Trial results: View results | |||||||||||||
| EudraCT Number: 2018-002661-19 | Sponsor Protocol Number: XSGP-304 | Start Date*: 2019-03-13 | |||||||||||
| Sponsor Name:Xeris Pharmaceuticals, Inc | |||||||||||||
| Full Title: G-PEN (GLUCAGON INJECTION) COMPARED TO GLUCAGEN® HYPOKIT® (GLUCAGON) FOR INDUCED HYPOGLYCEMIA RESCUE IN ADULTS WITH T1D: A PHASE 3 MULTI-CENTER, RANDOMIZED, CONTROLLED, SINGLE BLIND, 2-WAY CROSSOVE... | |||||||||||||
| Medical condition: treatment of severe hypoglycemia | |||||||||||||
|
|||||||||||||
| Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
| Trial protocol: DE (Completed) AT (Completed) | |||||||||||||
| Trial results: (No results available) | |||||||||||||
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
| Download Options: | |
|---|---|
| Number of Trials to download: | |
| Download Content: | |
| Download Format: | |
| Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. | |
Query did not match any studies.